AI Verdict
IDYA has stronger fundamentals based on our AI analysis.
IGTAW vs IDYA Fundamental Comparison
| Metric | IGTAW | IDYA |
|---|---|---|
| Revenue | N/A | $218.7M |
| Net Income | $-866,786.0 | $-113.7M |
| Net Margin | N/A | -52.0% |
| ROE | N/A | -11.1% |
| ROA | -38.3% | -10.2% |
| Current Ratio | 0.01x | 11.34x |
| Debt/Equity | N/A | 0.00x |
| EPS | $0.29 | $-1.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IGTAW vs IDYA: Frequently Asked Questions
Is IGTAW or IDYA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IDYA has stronger fundamentals. IGTAW is rated STRONG SELL (95% confidence) while IDYA is rated BUY (72% confidence). This is not investment advice.
How does IGTAW compare to IDYA fundamentally?
Inception Growth Acquisition Ltd has ROE of N/A vs IDEAYA Biosciences, Inc.'s -11.1%. Net margins are N/A vs -52.0% respectively.
Which stock pays higher dividends, IGTAW or IDYA?
IGTAW has a dividend yield of N/A or no dividend while IDYA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IGTAW or IDYA for long term?
For long-term investing, consider that IGTAW has STRONG SELL rating with 95% confidence, while IDYA has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IGTAW vs IDYA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IGTAW vs IDYA, the AI consensus favors IDYA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.